Bioharvest Sciences (BHST) Gross Margin (2023 - 2026)
Bioharvest Sciences (BHST) posted Gross Margin of 57.51% for the quarter ended Jun 30, 2026, down 2.22 percentage points from 59.73% a year earlier and down 1.70 percentage points from the prior quarter.
Bioharvest Sciences (BHST) Gross Margin (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Margin at Bioharvest Sciences was 58.95%, up 0.93 percentage points year-over-year; for the year ended Dec 31, 2025, it was 59.34%, up 3.99 percentage points from the prior year.
- In prior years, Bioharvest Sciences' Gross Margin was 55.35% in the year ended Dec 31, 2024 (+10.90 pp) and 44.45% in the year ended Dec 31, 2023.
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Gross Margin since the quarter ended Dec 31, 2024.
- On a year-over-year basis, Gross Margin increased in seven of the last eight quarters, with an average year-over-year change of +4.11 percentage points.
- The strongest year-over-year quarter for Gross Margin in the past five years was the quarter ended Sep 30, 2024, with a gain of 12.28 percentage points; the weakest was the quarter ended Jun 30, 2026, with a drop of 2.22 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 59.21% (quarter ended Mar 31, 2026), 57.63% (quarter ended Dec 31, 2025) and 61.43% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Bioharvest Sciences | 26.70 Mn | -43.69 Mn | 5.08 Mn | 57.51% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.51% |
| Mar 31, 2026 | 59.21% |
| Dec 31, 2025 | 57.63% |
| Sep 30, 2025 | 61.43% |
| Jun 30, 2025 | 59.73% |
| Mar 31, 2025 | 58.46% |
| Dec 31, 2024 | 56.65% |
| Sep 30, 2024 | 56.80% |
| Jun 30, 2024 | 51.47% |
| Mar 31, 2024 | 56.19% |
| Dec 31, 2023 | 50.73% |
| Sep 30, 2023 | 44.52% |
| Jun 30, 2023 | 40.22% |
Bioharvest Sciences Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=BHST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "BHST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=BHST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();